Summary:
1. REINHART PARTNERS, LLC. bought 91,788 shares of Axcelis Technologies, totaling approximately $7.39 million.
2. The transaction raised Axcelis Technologies to become the fund’s largest holding, accounting for 5.1% of their AUM.
3. Axcelis Technologies specializes in ion implantation equipment for semiconductor chip fabrication and is positioned to benefit from the growing demand for power semiconductors.
Rewritten Article:
On October 28, 2025, REINHART PARTNERS, LLC. made a significant investment by purchasing 91,788 shares of Axcelis Technologies, amounting to an estimated $7.39 million. This move elevated Axcelis Technologies to become the fund’s top holding, representing 5.1% of their Assets under Management (AUM).
Axcelis Technologies is a key player in the semiconductor industry, specializing in designing and manufacturing ion implantation equipment essential for semiconductor chip fabrication. Their product suite includes various implanters and lifecycle services, catering to semiconductor manufacturers globally.
The company’s strategic focus on ion implantation technology positions it well to capitalize on the increasing demand for power semiconductors used in electric vehicles, charging networks, and industrial equipment. With a strong engineering expertise and a dedicated approach to perfecting chip production, Axcelis Technologies stands out among its competitors.
Investors can find stability and growth potential in Axcelis Technologies, as their deep industry knowledge and service offerings provide a solid foundation for navigating market fluctuations. This investment signals confidence in the company’s future prospects and its ability to leverage the growing semiconductor market effectively.
